STOCKWATCH
·
Healthcare Service Provider
Quarterly Result4 Nov 2025, 03:02 pm

Vijaya Diagnostic Centre Announces Q2 & H1 FY26 Results with 10.2% & 14.9% YoY Revenue Growth Respectively

AI Summary

Vijaya Diagnostic Centre Limited, one of India’s leading integrated diagnostic chains, has announced its financial results for the quarter and half year ended 30th September 2025. The company reported a consolidated revenue from operations of Rs. 2,015.6 million in Q2 FY26, representing a YoY growth of 10.2%. The EBITDA for the quarter stood at Rs. 818.3 million, with an EBITDA margin of 40.6%. The company also announced a PAT of Rs. 432.8 million, with a PAT margin of 21.5%. The operational highlights include a total of 4.28 million tests and 1.20 million footfalls in Q2 FY26.

Key Highlights

  • Revenue from operations for Q2 FY26 stood at Rs. 2,015.6 million, with a YoY growth of 10.2%
  • EBITDA for Q2 FY26 was Rs. 818.3 million, with an EBITDA margin of 40.6%
  • PAT for Q2 FY26 was Rs. 432.8 million, with a PAT margin of 21.5%
  • Total tests for Q2 FY26 were 4.28 million, representing a YoY growth of 8.3%
  • Total footfalls for Q2 FY26 were 1.20 million, representing a YoY growth of 5.7%
VIJAYA
Healthcare Service Provider
Vijaya Diagnostic Centre Ltd

Price Impact